Jane Street’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.32M | Sell |
298,632
-428,165
| -59% | -$6.14M | ﹤0.01% | 3719 |
|
|
2025
Q4 | $10.3M | Sell |
726,797
-586,576
| -45% | -$5.76M | ﹤0.01% | 2277 |
|
|
2025
Q3 | $10.3M | Buy |
1,313,373
+764,529
| +139% | +$5.44M | ﹤0.01% | 2381 |
|
|
2025
Q2 | $3.14M | Sell |
548,844
-365,718
| -40% | -$2.36M | ﹤0.01% | 3681 |
|
|
2025
Q1 | $7.46M | Buy |
914,562
+590,292
| +182% | +$5.46M | ﹤0.01% | 2367 |
|
|
2024
Q4 | $3.05M | Sell |
324,270
-27,076
| -8% | -$281K | ﹤0.01% | 3412 |
|
|
2024
Q3 | $3.75M | Sell |
351,346
-280,920
| -44% | -$3.06M | ﹤0.01% | 3335 |
|
|
2024
Q2 | $6.27M | Buy |
632,266
+484,899
| +329% | +$4.98M | ﹤0.01% | 2645 |
|
|
2024
Q1 | $1.74M | Sell |
147,367
-114,966
| -44% | -$1.47M | ﹤0.01% | 4382 |
|
|
2023
Q4 | $3.72M | Buy |
262,333
+129,730
| +98% | +$1.47M | ﹤0.01% | 3298 |
|
|
2023
Q3 | $1.61M | Buy |
132,603
+8,600
| +7% | +$111K | ﹤0.01% | 4405 |
|
|
2023
Q2 | $1.56M | Buy |
124,003
+18,665
| +18% | +$221K | ﹤0.01% | 4533 |
|
|
2023
Q1 | $1.17M | Buy |
105,338
+36,609
| +53% | +$451K | ﹤0.01% | 4730 |
|
|
2022
Q4 | $839K | Buy |
68,729
+47,120
| +218% | +$530K | ﹤0.01% | 5246 |
|
|
2022
Q3 | $225K | Sell |
21,609
-38,696
| -64% | -$431K | ﹤0.01% | 7992 |
|
|
2022
Q2 | $647K | Sell |
60,305
-26,339
| -30% | -$217K | ﹤0.01% | 6272 |
|
|
2022
Q1 | $821K | Buy |
86,644
+16,629
| +24% | +$156K | ﹤0.01% | 6531 |
|
|
2021
Q4 | $808K | Sell |
70,015
-66,006
| -49% | -$736K | ﹤0.01% | 6338 |
|
|
2021
Q3 | $1.3M | Buy |
136,021
+2,836
| +2% | +$29K | ﹤0.01% | 5383 |
|
|
2021
Q2 | $1.28M | Buy |
133,185
+17,023
| +15% | +$166K | ﹤0.01% | 5263 |
|
|
2021
Q1 | $1.15M | Sell |
116,162
-5,009
| -4% | -$77.5K | ﹤0.01% | 5198 |
|
|
2020
Q4 | $2.8M | Buy |
121,171
+34,848
| +40% | +$713K | ﹤0.01% | 2913 |
|
|
2020
Q3 | $1.22M | Buy |
86,323
+74,297
| +618% | +$1.08M | ﹤0.01% | 3758 |
|
|
2020
Q2 | $181K | Sell |
12,026
-107,410
| -90% | -$1.31M | ﹤0.01% | 6431 |
|
|
2020
Q1 | $1.1M | Buy |
119,436
+40,336
| +51% | +$383K | ﹤0.01% | 2689 |
|
|
2019
Q4 | $770K | Buy |
+79,100
| New | +$724K | ﹤0.01% | 3135 |
|
|
2019
Q3 | – | Sell |
-43,078
| Closed | -$538K | – | 5283 |
|
|
2019
Q2 | $538K | Buy |
43,078
+5,812
| +16% | +$73.7K | ﹤0.01% | 3489 |
|
|
2019
Q1 | $507K | Buy |
37,266
+232
| +0.6% | +$2.83K | ﹤0.01% | 3665 |
|
|
2018
Q4 | $355K | Sell |
37,034
-28,811
| -44% | -$317K | ﹤0.01% | 3871 |
|
|
2018
Q3 | $796K | Buy |
65,845
+25,798
| +64% | +$361K | ﹤0.01% | 3044 |
|
|
2018
Q2 | $626K | Sell |
40,047
-68,071
| -63% | -$1.03M | ﹤0.01% | 3333 |
|
|
2018
Q1 | $1.63M | Buy |
108,118
+50,663
| +88% | +$771K | ﹤0.01% | 2091 |
|
|
2017
Q4 | $827K | Sell |
57,455
-22,952
| -29% | -$315K | ﹤0.01% | 2577 |
|
|
2017
Q3 | $1.21M | Buy |
80,407
+1,955
| +2% | +$25.9K | ﹤0.01% | 2096 |
|
|
2017
Q2 | $790K | Buy |
78,452
+25,597
| +48% | +$206K | ﹤0.01% | 2477 |
|
|
2017
Q1 | $377K | Buy |
52,855
+27,823
| +111% | +$176K | ﹤0.01% | 3187 |
|
|
2016
Q4 | $124K | Buy |
+25,032
| New | +$173K | ﹤0.01% | 3835 |
|
|
2016
Q3 | – | Sell |
-12,597
| Closed | -$69K | – | 4153 |
|
|
2016
Q2 | $69K | Sell |
12,597
-5,669
| -31% | -$39.6K | ﹤0.01% | 3935 |
|
|
2016
Q1 | $154K | Sell |
18,266
-37,101
| -67% | -$263K | ﹤0.01% | 3786 |
|
|
2015
Q4 | $537K | Buy |
+55,367
| New | +$499K | ﹤0.01% | 2402 |
|
|
2015
Q3 | – | Sell |
-50,508
| Closed | -$792K | – | 3753 |
|
|
2015
Q2 | $715K | Buy |
50,508
+9,680
| +24% | +$116K | ﹤0.01% | 1923 |
|
|
2015
Q1 | $444K | Buy |
+40,828
| New | +$360K | ﹤0.01% | 2163 |
|
|
2014
Q3 | – | Sell |
-446,057
| Closed | -$1.49M | – | 2705 |
|
|
2014
Q2 | $1.49M | Buy |
+446,057
| New | +$1.05M | 0.02% | 679 |
|
|
2013
Q4 | – | Sell |
-19,990
| Closed | -$46K | – | 2526 |
|
|
2013
Q3 | $46K | Buy |
+19,990
| New | +$50.2K | ﹤0.01% | 2609 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Jane Street's FOLD Position: Q1 2026 in Review
Jane Street reduced its Amicus Therapeutics (FOLD) stake by 59% in Q1 2026, selling an estimated $6.14M and leaving 298,632 shares worth $4.32M. The position accounts for ﹤0.01% of the portfolio, ranked #3719.
Jane Street first reported a position in FOLD in Q3 2013 and has held it in 44 quarters since. The position peaked at $10.3M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Jane Street held 298,632 shares of Amicus Therapeutics worth $4.32M as of Q1 2026.
- Jane Street sold 428,165 Amicus Therapeutics shares in Q1 2026, an estimated $6.14M.
- Amicus Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3719 holding.
- Jane Street first reported a position in Amicus Therapeutics in Q3 2013 and has held it in 44 quarters since.
- Jane Street's Amicus Therapeutics position peaked at $10.3M in Q4 2025.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.